Cell cycle-related biomarker lineage promotes the malignant progression of recurrent IDH wild-type glioma
This study developed a cell cycle-related signature for predicting the prognosis of recurrent IDH wild-type glioma, and identified a novel biomarker SYCE2, which could be used t...